Navigation Links
Intravenous Vitamin C (Ascorbate) for Cancer Treatment

Research has found that Intravenous Vitamin C administration in the form of Ascorbate was tested on nine cancer cell lines and four normal cell lines. The vitamin C did not have any effect or toxicity in normal cell // lines but Killed 50% of cancer cells in the tissue culture animal cell line and almost 100% sensitive on lymphoma cell lines.

Dr. Mark Levine and colleagues from Institute of Health, Maryland has reported the finding of their new study in the Proceedings of the National Academy of Sciences. The effective dose that killed the cancer cells were about 4 millimoles intravenously. The effect of Ascorbate on the cells is found by a chemical reaction in which the hydrogen peroxide produced toxicity to the cells. It is also proved earlier that Vitamin C destroys cancer cells by inducing Apoptosis (Programmed Cell death).

Dr. Mark Levine said that the anticancer effect of Ascorbate has to be tested on patients to find its efficacy and side effects, has many substances that have been shown to kill cancer cells in the lab but failed to fulfill that promise when tested in people. Henry Scowcroft, Senior Officer at Cancer Research UK, is not sure about the effect of Vitamin C on patients as the research is only on its initial stages. Dr. Mark Levine said, “But we do know that eating a healthy, balanced diet, including plenty of fresh fruit and vegetables, is an effective way to reduce the risk of getting cancer in the first place."
'"/>




Page: 1

Related medicine news :

1. Painkilling Patch As Effective As Intravenous Delivery Systems
2. Oral use of ZYVOX (Linezolid) is better to Intravenous Vancomycin use for Skin Infections
3. Intravenous Iron treats anemia of pregnancy faster
4. Advance in Program for Development of Non-Intravenous Therapy for Hemophilia
5. Intravenous Delivery of Clot-busting Drug Still Best Intervention for Ischemic Stroke
6. Vitamin B12 can help in detecting cancers
7. Vitamins-The answer to Heart Disease?
8. Vitamin E, the latest warrior against diabetes
9. Vitamin Shields Brittle Bones
10. B Vitamin protects and lowers toxicity of Arthritis Drug
11. B Vitamin Supplementatoin Saves Money and Lives
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: